Literature DB >> 28024604

Direct one-pot synthesis of glutathione capped hydrophilic FePt-CdS nanoprobe for efficient bimodal imaging application.

Deepak K Jha1, Koushik Saikia1, Srijita Chakrabarti2, Kakoli Bhattacharya1, Komanduri S Varadarajan3, Anant B Patel3, Danswrang Goyary2, P Chattopadhyay2, P Deb4.   

Abstract

One-pot synthesis methods for development of hydrophilic imaging nanoprobes have advantages over multi-pot methods due to their simple procedures, less probability for degradation of efficiency, superior control over growth and morphology, cost effectiveness, improved scope for scale-up synthesis etc. Here, we present a novel one-pot facile synthesis of hydrophilic colloidal bimodal nanoprobe (FePt-CdS) prepared through a seed-mediated nucleation and growth technique. In this facile synthesis of complex nanostructure, glutathione (GSH) was used as the capping agent to render biocompatibility and dispersibility. The microstructure, surface, optical, magnetic, biocompatibility, relaxivity and imaging property of the developed nanoprobe have been studied. The microstructural characterizations reveal average size of the particle as ~9-11nm with bleb shaped morphology. Spectroscopic characterization depicts the development of GSH capped CdS QDs on FePt, surface functionalities and their stability. The magnetic measurements confirm the superparamagnetic property in the developed bimodal nanoprobe. In addition, the GSH capping imparts excellent biocompatibility, water dispersibility, and fluorescence property to the probe. In RAW 264.7 macrophage cells, the bimodal nanoprobes exhibit intense green and red fluorescence. The magnetic resonance imaging (MRI) and fluorescence imaging (FI) study depict high transverse relaxivity and visible range fluorescent property in the synthesized FePt-CdS nanoprobe. Hence, the developed bimodal nanoprobe can be used as a potential candidate in simultaneous FI and MR imaging.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bimodal nanoprobe; Biofunctionalization; FePt-CdS; Magnetofluorescent imaging; One-pot hydrophilic; Superparamagnetic

Mesh:

Substances:

Year:  2016        PMID: 28024604     DOI: 10.1016/j.msec.2016.11.077

Source DB:  PubMed          Journal:  Mater Sci Eng C Mater Biol Appl        ISSN: 0928-4931            Impact factor:   7.328


  6 in total

1.  Influence of Cu on the Improvement of Magnetic Properties and Structure of L10 FePt Nanoparticles.

Authors:  Luran Zhang; Xinchen Du; Hongjie Lu; Dandan Gao; Huan Liu; Qilong Lin; Yongze Cao; Jiyang Xie; Wanbiao Hu
Journal:  Nanomaterials (Basel)       Date:  2021-04-23       Impact factor: 5.076

Review 2.  Quantum dots in imaging, drug delivery and sensor applications.

Authors:  Cristian T Matea; Teodora Mocan; Flaviu Tabaran; Teodora Pop; Ofelia Mosteanu; Cosmin Puia; Cornel Iancu; Lucian Mocan
Journal:  Int J Nanomedicine       Date:  2017-07-28

3.  FMSP-Nanoparticles Induced Cell Death on Human Breast Adenocarcinoma Cell Line (MCF-7 Cells): Morphometric Analysis.

Authors:  Firdos Alam Khan; Sultan Akhtar; Sarah Ameen Almofty; Dana Almohazey; Munthar Alomari
Journal:  Biomolecules       Date:  2018-05-23

4.  Magnetically guided theranostics: montmorillonite-based iron/platinum nanoparticles for enhancing in situ MRI contrast and hepatocellular carcinoma treatment.

Authors:  Ming-Hsien Chan; Chih-Ning Lu; Yi-Lung Chung; Yu-Chan Chang; Chien-Hsiu Li; Chi-Long Chen; Da-Hua Wei; Michael Hsiao
Journal:  J Nanobiotechnology       Date:  2021-10-09       Impact factor: 10.435

Review 5.  Tailor made magnetic nanolights: fabrication to cancer theranostics applications.

Authors:  Poushali Das; Sayan Ganguly; Shlomo Margel; Aharon Gedanken
Journal:  Nanoscale Adv       Date:  2021-10-25

Review 6.  Novel monodisperse FePt nanocomposites for T2-weighted magnetic resonance imaging: biomedical theranostics applications.

Authors:  Zhi-Xuan Chang; Chien-Hsiu Li; Yu-Chan Chang; Chi-Ying F Huang; Ming-Hsien Chan; Michael Hsiao
Journal:  Nanoscale Adv       Date:  2021-11-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.